Universal Health Realty Income Trust (UHT) stock analysis
Close on Nov 11, 2026Market cap $542.47MP/E 26.9Yield 7.58%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid16 of 30 checks passed
Universal Health Realty Income Trust passes 16 of the 30 checks behind our score; 4 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 3/6
- Growth
- 1/6
- Past performance
- 3/6
- Financial health
- 5/6
- Dividend
- 4/6
What stands out
Trading below fair value
The share price of $39.03 is below our fair value estimate of $40.34.
Return on capital over 10%
Return on invested capital was 19.8%, above the 10% that usually covers the cost of capital.
No debt
Universal Health Realty Income Trust has no borrowings on its latest balance sheet.
Earnings growth accelerating
Net income grew 12.4% over the last twelve months, against a 5-year average of -2.0% a year.
What to watch
Margin of safety under 20%
The price is 3.3% below fair value, less than the 20% cushion we look for.
Return on equity under 15%
Return on equity was 13.5% over the last twelve months and averaged 18.5% over five years; we look for 15% on both.
Earnings shrank over 5 years
Net income shrank 2.0% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew 3.1% a year over the last three fiscal years, short of the 10% we look for.
Valuation3/6
P/E below its 5-year median
Universal Health Realty Income Trust's P/E of 26.9 is below its own 5-year median of 31.6.
P/E above the industry
Universal Health Realty Income Trust's P/E of 26.9 is above the Miscellaneous Investing median of 26.3.
EV/EBITDA below its 5-year median
Universal Health Realty Income Trust's EV/EBITDA of 8.4 is below its 5-year median of 9.3.
P/B above the industry
Universal Health Realty Income Trust's price-to-book of 3.89 is above the Miscellaneous Investing median of 1.20.
Trading below fair value
The share price of $39.03 is below our fair value estimate of $40.34.
Margin of safety under 20%
The price is 3.3% below fair value, less than the 20% cushion we look for.
Growth1/6
Revenue growing under 10% a year
Revenue grew 3.1% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -6.0% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 12.4% over the last twelve months, against a 5-year average of -2.0% a year.
Growing slower than the industry
Revenue grew -0.0% over the last twelve months; the Miscellaneous Investing median is 4.6%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
This company does not report gross profit.
Past performance3/6
Return on equity under 15%
Return on equity was 13.5% over the last twelve months and averaged 18.5% over five years; we look for 15% on both.
Return on capital over 10%
Return on invested capital was 19.8%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Universal Health Realty Income Trust's return on equity of 13.5% is above the Miscellaneous Investing median of 3.1%.
Earnings shrank over 5 years
Net income shrank 2.0% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 20.3% over the last twelve months, against a 5-year average of 41.2%.
Net margin above the industry
Universal Health Realty Income Trust's net margin of 20.3% is above the Miscellaneous Investing median of 10.3%.
Financial health5/6
No debt
Universal Health Realty Income Trust has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
No meaningful interest expense to cover.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Low bankruptcy risk
The Altman Z-score is 3.28; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
Universal Health Realty Income Trust paid dividends worth 7.7% of the share price over the last twelve months.
Yield above Treasuries
The 7.7% yield is above the 4.4% on a 1-year Treasury.
Yield in the top quarter
The top quarter of US dividend payers yield 3.8% or more; Universal Health Realty Income Trust yields 7.7%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Not covered by earnings
Dividends take 206% of net income, leaving little room.
Cash-flow cover
Needs dividends paid and free cash flow.
Fair value
How we estimate itOur estimate per share
$40.34
The share price is 3% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 29.0× | 31.6× | 26.3× | $42.05 | 40% |
| EV/EBITDA | 9.4× | 9.3× | 9.5× | $43.48 | 35% |
| P/B | 2.1× | 3.1× | 1.2× | $21.54 | 10% |
| Earnings power | 7.7% cost of equity | – | – | $41.03 | 15% |
| Fair value | $40.34 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 31.6
- Miscellaneous Investing median 26.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $5.23M
- Value traded per 1% price move
- $4.41M
Downside
Low risk
- Typical loss in a bad month
- 9.6%
- Volatility (annualized)
- 23%
- Sharpe ratio, 1 year
- -0.19
- Beta to the S&P 500 (5Y)
- 0.56
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +0.2% | +3.1% | +4.9% | +4.5% | |
| Operating income | -5.5% | +4.3% | +6.0% | +5.4% | |
| Net income | -8.4% | -5.9% | -2.0% | -2.9% | |
| EPS, diluted | -8.6% | -6.0% | -2.1% | -3.3% | |
| Dividend per share | +1.4% | +1.4% | +1.4% | +1.5% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 8.9% | 11.4% | 10.6% | |
| Return on assets | 3.5% | 4.0% | 3.1% | |
| Capex to revenue | 90.0% | 2.9% | – | |
| Diluted shares | 0M | 14M | 14M |
Cash use needs five years of cash flow figures
Universal Health Realty Income Trust does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 17.8% | 0.17× | 3.45× | 10.6% |
| FY2024 | 19.4% | 0.17× | 3.09× | 10.1% |
| FY2023 | 16.1% | 0.16× | 2.80× | 7.2% |
| FY2022 | 23.3% | 0.15× | 2.60× | 9.1% |
| FY2021 | 129.7% | 0.15× | 2.77× | 55.4% |
| FY2020 | 24.9% | 0.16× | 2.88× | 11.4% |
| FY2019 | 24.6% | 0.16× | 2.56× | 10.0% |
| FY2018 | 31.7% | 0.16× | 2.38× | 11.8% |
| FY2017 | 63.1% | 0.14× | 2.53× | 22.7% |
| FY2016 | 25.7% | 0.14× | 2.55× | 8.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$17.61M
- Cash generatingOperating cash flow above zero$49.09M
- Return on assets improvedROA up on the prior year3.2% → 3.0%
- Earnings backed by cashOperating cash flow above net income$49.09M vs $17.61M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise14M → 14M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.17 → 0.17
See a number that looks wrong?